title: Diabetes insipidus.
abstract: Diabetes insipidus (DI) is characterized by hypotonic polyuria greater than 3 liters/24 hours in adults and persisting even during water deprivation. It is mostly due to a defect in arginin-vasopressin (AVP) synthesis (central DI); other causes are: AVP resistance (nephrogenic DI), abnormal thirst regulation (primary polydipsia) or early destruction of AVP by placental enzymes (gestational DI). A thorough medical history is warranted to investigate nocturnal persistence of polyuria (night waking being a good sign of its organic nature) to specify the onset and duration of the trouble, the medication use and the potential hereditary nature of the disorder. The next step is based on weight and blood pressure measurements and especially the quantification of beverages and diuresis over a 24-hour cycle. Assessment of signs of dehydration, bladder distention, pituitary hormone hyper- or hyposecretion, tumor chiasmatic syndrome, granulomatosis and cancer is required. The diagnosis is based on biological assessment, pituitary magnetic resonance imaging (MRI) and results of a desmopressin test. In severe forms of DI, urine osmolality remains below 250 mOsmol/kg and serum sodium greater than 145 mmol/L. In partial forms of DI (urine osmolality between 250 and 750), the water deprivation test demonstrating the incapacity to obtain a maximal urine concentration is valuable, together with vasopressin or copeptin measurement. The pituitary MRI is done to investigate the lack of spontaneous hyperintensity signal in the posterior pituitary, which marks the absence of AVP and supports the diagnosis of central DI rather than primary polydipsia (although not absolute); it can also recognize lesions of the pituitary gland or pituitary stalk. Acquired central DI of sudden onset should suggest a craniopharyngioma or germinoma if it occurs before the age of 30 years, and metastasis after the age of 50 years. Fifteen to 20% of head trauma lead to hypopituitarism, including DI in 2% of cases. Transient or permanent DI is present in 8-9% of endoscopic transphenoidal surgeries. Current advances in DI concern the etiological work-up, with in particular the identification of IgG4-related hypophysitis or many genetic abnormalities, opening the field of targeted therapies in the years to come.
authors.affiliation: Service d'endocrinologie et maladies métaboliques, centre hospitalier régional universitaire de Lille (CHRU de LIlle), hôpital Huriez/Inserm U 859, 1, rue Polonovski, 59000 Lille, France.
authors.forename: Clara
authors.initials: C
authors.lastname: Leroy
authors.forename: Wassila
authors.initials: W
authors.lastname: Karrouz
authors.forename: Claire
authors.initials: C
authors.lastname: Douillard
authors.forename: Christine
authors.initials: C
authors.lastname: Do Cao
authors.forename: Christine
authors.initials: C
authors.lastname: Cortet
authors.forename: Jean-Louis
authors.initials: JL
authors.lastname: Wémeau
authors.forename: Marie-Christine
authors.initials: MC
authors.lastname: Vantyghem
mesh_terms: D000328:Adult; D003919:Diabetes Insipidus / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003937:Diagnosis, Differential; D003940:Diagnostic Techniques, Endocrine; D006801:Humans; D059607:Polydipsia, Psychogenic / Q000175:diagnosis / Q000209:etiology; D014867:Water / Q000378:metabolism; D014882:Water-Electrolyte Balance / Q000502:physiology
chemical_list: D014867:Water